• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Endoscopic surveillance of superficial papillary tumors of the bladder].

作者信息

Desrez G, Mandron E, Chatelain C

机构信息

Clinique urologique, groupe hospitalier Pitié-Salpêtrière, Paris, France.

出版信息

Cancer Radiother. 1998 Apr;2 Suppl 1:27s-30s.

PMID:9749074
Abstract

All cases of superficial bladder tumor treated in 1991 at the urology department of La Pitié hospital were reviewed to study the course of superficial bladder tumors with regard to the risk of muscle infiltration and the value of endoscopic follow-up. In 1991, 73 patients (63 men and 10 women) with a mean age of 64 years had TUR for superficial bladder tumor. Patients had repeated cystoscopy at 3 and 6 months and then on a yearly basis for 5 years. Fourty-eight patients had TIS tumors, and 19 patients had T1 tumors. Five patients were lost to follow-up. Sixty-eight patients were followed for 5 years. Of 48 patients with stage TIS tumors, 39 (81.5%) did not show any deterioration at histological examination, eight patients (16.5%) had infiltration of the lamina propria by tumor (pT1) and the tumor invaded muscle in one patient (2%). Of the 19 patients with stage T1 tumors at the first TUR eight (47%) had no pathologic deterioration, but nine (53%) developed muscle invasion (pT2). Two patients were lost to follow-up. Invasion of the lamina propria present at diagnosis or during the subsequent course is considered to be an indicator of high risk of progression to muscle invasive disease (over 50% of cases). The prognostic accuracy of both the grade and stage needs to be enhanced using molecular markers.

摘要

相似文献

1
[Endoscopic surveillance of superficial papillary tumors of the bladder].
Cancer Radiother. 1998 Apr;2 Suppl 1:27s-30s.
2
Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.高危浅表性膀胱肿瘤患者膀胱内卡介苗治疗失败后的膀胱切除术:术前前列腺受累作为一个预后因素。
Eur Urol. 2005 Jul;48(1):53-9; discussion 59. doi: 10.1016/j.eururo.2005.03.021. Epub 2005 Apr 7.
3
Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.上尿路移行细胞癌行肾输尿管切除术或输尿管节段切除术后膀胱肿瘤的病理特征。
Urology. 2007 Feb;69(2):251-4. doi: 10.1016/j.urology.2006.09.065.
4
Watchful waiting policy in recurrent Ta G1 bladder tumors.复发性Ta G1膀胱肿瘤的观察等待策略
Eur Urol. 2006 Feb;49(2):303-6; discussion 306-7. doi: 10.1016/j.eururo.2005.12.029. Epub 2006 Jan 6.
5
Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.高危浅表性膀胱癌的再次经尿道切除术可改善对卡介苗治疗的初始反应。
J Urol. 2005 Dec;174(6):2134-7. doi: 10.1097/01.ju.0000181799.81119.fc.
6
[Surveillance and prognosis of "T1" superficial tumors of the bladder. Homogeneous series of 88 cases followed for 1 to 22 years].[膀胱“T1”期浅表肿瘤的监测与预后。88例同质系列病例随访1至22年]
Prog Urol. 2001 Jun;11(3):472-7.
7
Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.低剂量卡介苗灌注治疗Ta3期膀胱肿瘤的复发、进展及疗效
J Urol. 2000 Jan;163(1):63-7.
8
[Radical cystectomy for superficial tumors in the BCG era].[卡介苗(BCG)时代针对浅表肿瘤的根治性膀胱切除术]
Arch Esp Urol. 2002 Jan-Feb;55(1):50-6.
9
[Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma].[浅表性膀胱癌患者治疗的现代随访策略]
Z Arztl Fortbild Qualitatssich. 2000 Aug;94(6):519-27.
10
Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.局部膀胱热疗联合膀胱内化疗治疗高级别浅表性膀胱癌。
Urology. 2004 Mar;63(3):466-71. doi: 10.1016/j.urology.2003.10.036.